Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PATRICIA LYNN BONONI

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1730105586
CMS profile
213767
Location
PITTSBURGH, PA

General Payments · PY2018–2024

$79,860.83

  • Reported across 212 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,251.09

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $5,177.34 12
Amgen Inc. $276.47 4
CeQur Corporation $205.99 1
BETA BIONICS, INC. $181.43 2
W. L. Gore & Associates, Inc. $138.91 1
Abbott Laboratories $103.62 2
Lilly USA, LLC $57.71 3
Neurocrine BioSciences, Inc. $28.37 1
Xeris Pharmaceuticals, Inc. $24.51 1
Tandem Diabetes Care, Inc. $21.23 1
DEXCOM, INC. $20.51 1
Medtronic, Inc. $15.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,299.53 9
PY2019 $15,458.41 55
PY2020 $506.02 7
PY2021 $19,029.25 24
PY2022 $26,347.65 47
PY2023 $10,968.88 40
PY2024 $6,251.09 30

Payment records · PY2024 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $88.89 03/08/2024 Food and Beverage Undisputed 01/23/2026 1125220350 CMS
Abbott Laboratories $14.73 03/08/2024 Food and Beverage Undisputed 01/23/2026 1125220352 CMS
Amgen Inc. $121.84 03/13/2024 Food and Beverage Undisputed 01/23/2026 1115457679 CMS
Amgen Inc. $14.83 04/02/2024 Food and Beverage Undisputed 01/23/2026 1115457676 CMS
Amgen Inc. $56.80 05/21/2024 Food and Beverage Undisputed 01/23/2026 1115457687 CMS
Amgen Inc. $83.00 08/28/2024 Food and Beverage Undisputed 01/23/2026 1115457683 CMS
BETA BIONICS, INC. $33.43 08/02/2024 Food and Beverage Undisputed 01/23/2026 1087880969 CMS
BETA BIONICS, INC. $148.00 08/02/2024 Food and Beverage Undisputed 01/23/2026 1087880981 CMS
CeQur Corporation $205.99 01/10/2024 Food and Beverage Undisputed 01/23/2026 1126846680 CMS
Dexcom, Inc. $20.51 05/19/2024 Food and Beverage Undisputed 01/23/2026 1153327303 CMS
Lilly USA, LLC $19.05 01/23/2024 Food and Beverage Undisputed 01/23/2026 1135308537 CMS
Lilly USA, LLC $18.45 01/29/2024 Food and Beverage Undisputed 01/23/2026 1135269009 CMS
Lilly USA, LLC $20.21 02/15/2024 Food and Beverage Undisputed 01/23/2026 1135263001 CMS
Medtronic, Inc. $15.00 05/03/2024 Food and Beverage Undisputed 01/23/2026 1119455801 CMS
Neurocrine Biosciences, Inc. $28.37 11/15/2024 Food and Beverage Undisputed 01/23/2026 1150829750 CMS
Novo Nordisk Inc $1,754.50 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096922654 CMS
Novo Nordisk Inc $22.60 06/14/2024 Food and Beverage Undisputed 01/23/2026 1097667696 CMS
Novo Nordisk Inc $20.11 06/18/2024 Food and Beverage Undisputed 01/23/2026 1097326663 CMS
Novo Nordisk Inc $18.35 07/10/2024 Food and Beverage Undisputed 01/23/2026 1096688668 CMS
Novo Nordisk Inc $750.00 09/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097273458 CMS
Novo Nordisk Inc $16.78 09/13/2024 Food and Beverage Undisputed 01/23/2026 1097379523 CMS
Novo Nordisk Inc $1,687.50 09/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096920076 CMS
Novo Nordisk Inc $105.96 09/18/2024 Food and Beverage Undisputed 01/23/2026 1097814335 CMS
Novo Nordisk Inc $24.46 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097313066 CMS
Novo Nordisk Inc $20.32 10/22/2024 Food and Beverage Undisputed 01/23/2026 1096900525 CMS
Novo Nordisk Inc $750.00 10/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097758402 CMS
Novo Nordisk Inc $6.76 11/19/2024 Food and Beverage Undisputed 01/23/2026 1097159480 CMS
Tandem Diabetes Care, Inc. $21.23 03/21/2024 Food and Beverage Undisputed 01/23/2026 1138744333 CMS
W. L. Gore & Associates, Inc. $138.91 04/25/2024 Food and Beverage Undisputed 01/23/2026 1148156431 CMS
Xeris Pharmaceuticals, Inc. $24.51 05/30/2024 Food and Beverage Undisputed 01/23/2026 1144608579 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.